Donald M. Gleason

A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma

Fred Saad, Donald M. Gleason, Robin Murray et al. · JNCI Journal of the National Cancer Institute · 2002 · 1.7K citations · Full text

Randomized Controlled Trial of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer

Matthew R. Smith, James A. Eastham, Donald M. Gleason et al. · The Journal of Urology · 2003 · 644 citations

Standardization of terminology of lower urinary tract function: Pressure-flow studies of voiding, urethral resistance, and urethral obstruction

Derek Griffiths, K. Höfner, R. van Mastrigt et al. · Neurourology and Urodynamics · 1997 · 456 citations · Full text

Clinical Efficacy and Safety of Tolterodine Compared to Oxybutynin and Placebo in Patients with Overactive Bladder

Harold P. Drutz, Rodney A. Appell, Donald M. Gleason et al. · International Urogynecology Journal · 1999 · 234 citations

Urological Research, Urology, Voiding Dysfunction +7

Bicalutamide as Immediate Therapy Either Alone or as Adjuvant to Standard Care of Patients with Localized or Locally Advanced Prostate Cancer: First Analysis of the Early Prostate Cancer Program

William A. See, Manfred P. Wirth, David G. McLeod et al. · The Journal of Urology · 2002 · 229 citations